(Q44814113)

English

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes

scientific article published in March 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

Edwin A.M. Gale

1

object named as

E A M Gale

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Polly J. Bingley

2

object named as

P J Bingley

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

C L Emmett

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

T Collier

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

European Nicotinamide Diabetes Intervention Trial (ENDIT) Group

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

363

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

9413

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

925-931

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

The NOD mouse model of type 1 diabetes: as good as it gets?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposed guidelines on screening for risk of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. The Nicotinamide Trialists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A population based strategy to prevent insulin-dependent diabetes using nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention or delay of Type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of high-dose nicotinamide: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Standardization of IVGTT to predict IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of IDDM in the General Population: Strategies Based on Combinations of Autoantibody Markers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of bolus and infusion protocols for determining acute insulin response to intravenous glucose in normal humans. The ICARUS Group. Islet Cell Antibody Register User's Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross sectional stature and weight reference curves for the UK, 1990

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on the ability of compounds to block the diabetogenic activity of streptozotocin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Preventive and Therapeutic Effects of Large-Dose Nicotinamide Injections on Diabetes Associated with Insulitis: An Observation in Nonobese Diabetic (NOD) Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nicotinamide treatment in the prevention of insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nicotinamide--biological actions and therapeutic potential in diabetes prevention. IDIG Workshop, Copenhagen, Denmark, 4-5 December 1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacokinetics of nicotinamide in humans and rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nicotinamide protects human beta cells against chemically-induced necrosis, but not against cytokine-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Can we change the course of beta-cell destruction in type 1 diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915786-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(04)15786-3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44814113&oldid=2134787046"